AMIT Moran

Post-translational Regulation of Radioactive Iodine Therapy Response in Papillary Thyroid Carcinoma

Published date : 08 Sep 2017

Background
Radioactive iodine (RAI) is the mainstay of treatment for differentiated thyroid carcinoma (DTC). Nevertheless, the mechanism of RAI resistance that occurs in many patients with DTC remains unknown. We aimed to elucidate the role of post-translational regulation of radioiodine uptake.

Methods

type
Journal Paper
journal
JNCI: Journal of the national Cancer Institute, 2017, Vol. 109, Issue 12, 1 Dec 2017, doi: 10.1093/jnci/djx092
Impact Factor
12.589